Download - WHOCC

QJ01E
SULFONAMIDES AND TRIMETHOPRIM
Sulfonamides and trimethoprim are classified differently in the ATCvet system,
compared with the ATC system, owing to differences in their pharmacokinetics and
metabolism in animals, compared with humans.
Systemic sulfonamides and trimethoprim and/or derivatives are classified in this
group.
Combinations of sulfonamide and trimethoprim, and/or derivatives, are classified in
QJ01EW. Preparations containing two or more sulfonamides are classified using
the 5th level code 30. Sulfonamides combined with other antibacterials (excluding
trimethoprim and analogues) are classified in QJ01R - Combinations of of
antibacterials. See also QA07A - Intestinal antiinfectives.
QJ01EA
QJ01EQ
Trimethoprim and derivatives
Sulfonamides
Sulfonamides indicated in treatment of paracitic infections are classified in
QP51AG - Sulfonamides, plain and in combinations.
Combination products should be classified in separate 5th level groups using the
corresponding 50 series except for combinations with trimethoprim and derivatives
which are classified in QJ01EW. Combinations of two or more sulfonamides
should be classified using the 5th level code 30.
Oral antiinfectives, which have no systemic effect, are classified in QA07A.
QJ01EW
Combinations of sulfonamides and trimethoprim, incl. derivatives
Combinations with trimethoprim, including derivatives, are classified in the same
5th level group according to the sulfonamide. Combinations of two or more
sulfonamides and trimethoprime, incl. derivatives, should be classified using the
5th level code 30.
QJ01F
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Macrolide, lincosamide and streptogramin antibacterials inhibiting bacterial protein
synthesis through binding to the 50-S part of the ribosomes are classified in this
group.
QJ01FA
QJ01FF
Macrolides
Lincosamides
119